A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
Clinical trial NCT07156201 · RECRUITING
Trial details
- NCT number
- NCT07156201
- Sponsor
- Actio Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2026-12-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.